AllTest SARS-CoV-2 / Influenza A+B / RSV combo rapid test
Generally
AllTest SARS-CoV-2 / Influenza A+B / RSV combo rapid test is a qualitative chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein, influenza A + B, and RSV antigens.
AllTest SARS-CoV-2 / Influenza A+B / RSV combo rapid test dipstick is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein, influenza A, influenza B and respiratory syncytial virus (RSV) antigens in human nasopharyngeal or nasal swab specimens. Results are for the detection of antigens from individuals with suspected SARS-CoV-2 / Influenza / RSV infection in conjunction with clinical presentation and the results of other laboratory tests. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection.
The test kit contains necessary test materials, as well as negative and positive controls. Test results are ready after 15 minutes.
AllTest SARS-CoV-2 / Influenza A+B / RSV combo rapid test benefits
- Simple test procedure
- Clear colour reactions for easy interpretation of results
- Accurate results in 15 minutes
- Contains needed test materials and controls
Technical data
Products available | AllTest SARS-CoV-2 / Influenza A+B / RSV combo rapid test dipstick, 20T (product no ISIR-535, order no 155367) |
Use | For professional in vitro diagnostics |
Method | Chromatographic immunoassay |
Sample type | Nasal or nasopharyngeal swab specimen |
Time to result | 15 minutes |
Reading of the result | Visual |
Storage | 2 - 30°C |
Sensitivity | SARS-CoV-2: 97.0 % (nasopharyngeal or nasal swab) Influenza B: 92.9 % (nasopharyngeal swab), 94.1 % (nasal swab) |
Specificity | SARS-CoV-2: 99.0% (nasopharyngeal swab), 99.6% (nasal swab) |
| Registered trademark* | A ALLTEST is a trademark of Hangzhou AllTest Biotech Co, Ltd. |
More information
Read more: HANGZHOU ALLTEST BIOTECH CO.,LTD